Australia - English - Department of Health (Therapeutic Goods Administration)

naton medical aus pty ltd - 63308 - electrolytic-plasma electrosurgical system - the electrolytic-plasma electrosurgical systems (model: rfs-100a) is a bipolar, radiofrequency (rf) electrosurgical system is designed for resection, ablation, and coagulation of soft tissue and hemostasis of blood vessels. each system consists of a controller, a reusable, non-sterile foot control, a reusable flow control unit, a reusable flow control cable, and a disposable plasma wand.

Australia - English - Department of Health (Therapeutic Goods Administration)

bravamed pty ltd - 63309 - electrolytic-plasma endoscopic electrosurgical electrode - electrodes are used by connected with the plasma device. they are indicated for resection, ablation, and coagulation of soft tissue in the joint and hemostasis in clinical practice.

Australia - English - Department of Health (Therapeutic Goods Administration)

bravamed pty ltd - 63308 - electrolytic-plasma electrosurgical system - the generator is intended to deliver radio frequency energy for resection, ablation and coagulation of soft tissue and homeostasis in orthopaedic, arthroscopic, spinal and general surgical procedures.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - potassium chloride; sodium chloride - solution for infusion - 0.15% w/v + 0.9 percent weight/volume - solutions affecting the electrolyte balance; electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

endocare anz pty ltd - 63308 - electrolytic-plasma electrosurgical system - radio frequency plasma surgical system with plasma electrodes which provides rapid and efficient ablation and resection capabilities as well as coagulation and haemostasis of soft tissue in a relatively low temperature.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - potassium chloride - concentrate for solution for infusion - 15 percent weight/volume - electrolyte solutions; potassium chloride

Australia - English - Department of Health (Therapeutic Goods Administration)

magnesium chloride; glucose; acetic acid; sodium chloride; potassium chloride; calcium chloride -

Malta - English - Medicines Authority

sofar s.p.a via isonzo 8, 20135 - milano, italy - mesalazine - gastro-resistant tablet - mesalazine 400 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride - concentrate for soln for inf - 15 %w/v - potassium chloride

United States - English - NLM (National Library of Medicine)

a-s medication solutions - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with its use (see warnings below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hydrochloride tablets favorably affects survival. amiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring